Cargando…

Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications

Liver transplantation is currently the only curative therapy for patients with acute or chronic liver failure. However, a dramatic gap between the number of available liver grafts and the number of patients on the transplantation waiting list emphasizes the need for valid liver substitutes. Whole-or...

Descripción completa

Detalles Bibliográficos
Autores principales: Toprakhisar, Burak, Verfaillie, Catherine M., Kumar, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856398/
https://www.ncbi.nlm.nih.gov/pubmed/36672236
http://dx.doi.org/10.3390/cells12020301
_version_ 1784873615679815680
author Toprakhisar, Burak
Verfaillie, Catherine M.
Kumar, Manoj
author_facet Toprakhisar, Burak
Verfaillie, Catherine M.
Kumar, Manoj
author_sort Toprakhisar, Burak
collection PubMed
description Liver transplantation is currently the only curative therapy for patients with acute or chronic liver failure. However, a dramatic gap between the number of available liver grafts and the number of patients on the transplantation waiting list emphasizes the need for valid liver substitutes. Whole-organ engineering is an emerging field of tissue engineering and regenerative medicine. It aims to generate transplantable and functional organs to support patients on transplantation waiting lists until a graft becomes available. It comprises two base technologies developed in the last decade; (1) organ decellularization to generate a three-dimensional (3D) extracellular matrix scaffold of an organ, and (2) scaffold recellularization to repopulate both the parenchymal and vascular compartments of a decellularized organ. In this review article, recent advancements in both technologies, in relation to liver whole-organ engineering, are presented. We address the potential sources of hepatocytes and non-parenchymal liver cells for repopulation studies, and the role of stem-cell-derived liver progeny is discussed. In addition, different cell seeding strategies, possible graft modifications, and methods used to evaluate the functionality of recellularized liver grafts are outlined. Based on the knowledge gathered from recent transplantation studies, future directions are summarized.
format Online
Article
Text
id pubmed-9856398
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98563982023-01-21 Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications Toprakhisar, Burak Verfaillie, Catherine M. Kumar, Manoj Cells Review Liver transplantation is currently the only curative therapy for patients with acute or chronic liver failure. However, a dramatic gap between the number of available liver grafts and the number of patients on the transplantation waiting list emphasizes the need for valid liver substitutes. Whole-organ engineering is an emerging field of tissue engineering and regenerative medicine. It aims to generate transplantable and functional organs to support patients on transplantation waiting lists until a graft becomes available. It comprises two base technologies developed in the last decade; (1) organ decellularization to generate a three-dimensional (3D) extracellular matrix scaffold of an organ, and (2) scaffold recellularization to repopulate both the parenchymal and vascular compartments of a decellularized organ. In this review article, recent advancements in both technologies, in relation to liver whole-organ engineering, are presented. We address the potential sources of hepatocytes and non-parenchymal liver cells for repopulation studies, and the role of stem-cell-derived liver progeny is discussed. In addition, different cell seeding strategies, possible graft modifications, and methods used to evaluate the functionality of recellularized liver grafts are outlined. Based on the knowledge gathered from recent transplantation studies, future directions are summarized. MDPI 2023-01-13 /pmc/articles/PMC9856398/ /pubmed/36672236 http://dx.doi.org/10.3390/cells12020301 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Toprakhisar, Burak
Verfaillie, Catherine M.
Kumar, Manoj
Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications
title Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications
title_full Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications
title_fullStr Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications
title_full_unstemmed Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications
title_short Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications
title_sort advances in recellularization of decellularized liver grafts with different liver (stem) cells: towards clinical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856398/
https://www.ncbi.nlm.nih.gov/pubmed/36672236
http://dx.doi.org/10.3390/cells12020301
work_keys_str_mv AT toprakhisarburak advancesinrecellularizationofdecellularizedlivergraftswithdifferentliverstemcellstowardsclinicalapplications
AT verfailliecatherinem advancesinrecellularizationofdecellularizedlivergraftswithdifferentliverstemcellstowardsclinicalapplications
AT kumarmanoj advancesinrecellularizationofdecellularizedlivergraftswithdifferentliverstemcellstowardsclinicalapplications